These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1487 related items for PubMed ID: 24374878

  • 1. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 3. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 4. Fecal calprotectin testing can identify ineffective colorectal cancer surveillance procedures in patients with longstanding colitis.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Jun; 20(6):1079-84. PubMed ID: 24788218
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V, Chaparro M, Gisbert JP.
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [Abstract] [Full Text] [Related]

  • 6. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O, Ohem J, Mitrova K, Durilova M, Kotalova R, Nevoral J, Kolho KL, Bronsky J.
    Clin Lab; 2014 Nov; 60(12):1993-2000. PubMed ID: 25651733
    [Abstract] [Full Text] [Related]

  • 8. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L, Mosli M, Chande N, Yan B, Beaton M, Micsko J, Mennill PW, Barnett W, Bax K, Ponich T, Howard J, Tirolese A, Lannigan R, Gregor J.
    Saudi J Gastroenterol; 2015 Nov; 21(6):360-6. PubMed ID: 26655130
    [Abstract] [Full Text] [Related]

  • 9. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [Abstract] [Full Text] [Related]

  • 10. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 May; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 11. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, DʼIncà R, Barberio B, Stronati L.
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [Abstract] [Full Text] [Related]

  • 12. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 13. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW, Lee KM, Lee JM, Chung YY, Kim DB, Kim YJ, Chung WC, Paik CN.
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [Abstract] [Full Text] [Related]

  • 14. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [Abstract] [Full Text] [Related]

  • 15. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J, Yanai S, Nakamura S, Kawasaki K, Akasaka R, Sato K, Toya Y, Asakura K, Gonai T, Sugai T, Matsumoto T.
    World J Gastroenterol; 2018 Oct 14; 24(38):4384-4392. PubMed ID: 30344422
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z, Clark N, Park KT.
    Clin Gastroenterol Hepatol; 2014 Feb 14; 12(2):253-62.e2. PubMed ID: 23883663
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Ma C, Lumb R, Walker EV, Foshaug RR, Dang TT, Verma S, Huang VW, Kroeker KI, Wong K, Dieleman LA, Fedorak RN, Halloran BP.
    Inflamm Bowel Dis; 2017 Sep 14; 23(9):1643-1649. PubMed ID: 28644184
    [Abstract] [Full Text] [Related]

  • 18. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD, Hoskin T, Meijer B, Ashcroft A, Walmsley R, Day AS, Gearry RB.
    Inflamm Bowel Dis; 2015 Apr 14; 21(4):824-31. PubMed ID: 25738372
    [Abstract] [Full Text] [Related]

  • 19. Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    J Clin Gastroenterol; 2018 Aug 14; 52(7):e53-e62. PubMed ID: 28723856
    [Abstract] [Full Text] [Related]

  • 20. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F.
    Scand J Gastroenterol; 2014 Dec 14; 49(12):1419-24. PubMed ID: 25369978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.